Global Long-Acting Monoclonal Antibodies Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Long-Acting Monoclonal Antibodies Market Size 2017-2028

2.1.2 Long-Acting Monoclonal Antibodies Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Long-Acting Monoclonal Antibodies Segment by Type

2.2.1 Murine Source

2.2.2 Chimeric Source

2.2.3 Human Source

2.3 Long-Acting Monoclonal Antibodies Market Size by Type

2.3.1 Long-Acting Monoclonal Antibodies Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Long-Acting Monoclonal Antibodies Market Size Market Share by Type (2017-2022)

2.4 Long-Acting Monoclonal Antibodies Segment by Application

2.4.1 Cancer

2.4.2 Autoimmune Diseases

2.4.3 Inflammatory Diseases

2.4.4 Infectious Diseases

2.4.5 Others

2.5 Long-Acting Monoclonal Antibodies Market Size by Application

2.5.1 Long-Acting Monoclonal Antibodies Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Long-Acting Monoclonal Antibodies Market Size Market Share by Application (2017-2022)

3 Long-Acting Monoclonal Antibodies Market Size by Player

3.1 Long-Acting Monoclonal Antibodies Market Size Market Share by Players

3.1.1 Global Long-Acting Monoclonal Antibodies Revenue by Players (2020-2022)

3.1.2 Global Long-Acting Monoclonal Antibodies Revenue Market Share by Players (2020-2022)

3.2 Global Long-Acting Monoclonal Antibodies Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Long-Acting Monoclonal Antibodies by Regions

4.1 Long-Acting Monoclonal Antibodies Market Size by Regions (2017-2022)

4.2 Americas Long-Acting Monoclonal Antibodies Market Size Growth (2017-2022)

4.3 APAC Long-Acting Monoclonal Antibodies Market Size Growth (2017-2022)

4.4 Europe Long-Acting Monoclonal Antibodies Market Size Growth (2017-2022)

4.5 Middle East & Africa Long-Acting Monoclonal Antibodies Market Size Growth (2017-2022)

5 Americas

5.1 Americas Long-Acting Monoclonal Antibodies Market Size by Country (2017-2022)

5.2 Americas Long-Acting Monoclonal Antibodies Market Size by Type (2017-2022)

5.3 Americas Long-Acting Monoclonal Antibodies Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Long-Acting Monoclonal Antibodies Market Size by Region (2017-2022)

6.2 APAC Long-Acting Monoclonal Antibodies Market Size by Type (2017-2022)

6.3 APAC Long-Acting Monoclonal Antibodies Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Long-Acting Monoclonal Antibodies by Country (2017-2022)

7.2 Europe Long-Acting Monoclonal Antibodies Market Size by Type (2017-2022)

7.3 Europe Long-Acting Monoclonal Antibodies Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Long-Acting Monoclonal Antibodies by Region (2017-2022)

8.2 Middle East & Africa Long-Acting Monoclonal Antibodies Market Size by Type (2017-2022)

8.3 Middle East & Africa Long-Acting Monoclonal Antibodies Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Long-Acting Monoclonal Antibodies Market Forecast

10.1 Global Long-Acting Monoclonal Antibodies Forecast by Regions (2023-2028)

10.1.1 Global Long-Acting Monoclonal Antibodies Forecast by Regions (2023-2028)

10.1.2 Americas Long-Acting Monoclonal Antibodies Forecast

10.1.3 APAC Long-Acting Monoclonal Antibodies Forecast

10.1.4 Europe Long-Acting Monoclonal Antibodies Forecast

10.1.5 Middle East & Africa Long-Acting Monoclonal Antibodies Forecast

10.2 Americas Long-Acting Monoclonal Antibodies Forecast by Country (2023-2028)

10.2.1 United States Long-Acting Monoclonal Antibodies Market Forecast

10.2.2 Canada Long-Acting Monoclonal Antibodies Market Forecast

10.2.3 Mexico Long-Acting Monoclonal Antibodies Market Forecast

10.2.4 Brazil Long-Acting Monoclonal Antibodies Market Forecast

10.3 APAC Long-Acting Monoclonal Antibodies Forecast by Region (2023-2028)

10.3.1 China Long-Acting Monoclonal Antibodies Market Forecast

10.3.2 Japan Long-Acting Monoclonal Antibodies Market Forecast

10.3.3 Korea Long-Acting Monoclonal Antibodies Market Forecast

10.3.4 Southeast Asia Long-Acting Monoclonal Antibodies Market Forecast

10.3.5 India Long-Acting Monoclonal Antibodies Market Forecast

10.3.6 Australia Long-Acting Monoclonal Antibodies Market Forecast

10.4 Europe Long-Acting Monoclonal Antibodies Forecast by Country (2023-2028)

10.4.1 Germany Long-Acting Monoclonal Antibodies Market Forecast

10.4.2 France Long-Acting Monoclonal Antibodies Market Forecast

10.4.3 UK Long-Acting Monoclonal Antibodies Market Forecast

10.4.4 Italy Long-Acting Monoclonal Antibodies Market Forecast

10.4.5 Russia Long-Acting Monoclonal Antibodies Market Forecast

10.5 Middle East & Africa Long-Acting Monoclonal Antibodies Forecast by Region (2023-2028)

10.5.1 Egypt Long-Acting Monoclonal Antibodies Market Forecast

10.5.2 South Africa Long-Acting Monoclonal Antibodies Market Forecast

10.5.3 Israel Long-Acting Monoclonal Antibodies Market Forecast

10.5.4 Turkey Long-Acting Monoclonal Antibodies Market Forecast

10.5.5 GCC Countries Long-Acting Monoclonal Antibodies Market Forecast

10.6 Global Long-Acting Monoclonal Antibodies Forecast by Type (2023-2028)

10.7 Global Long-Acting Monoclonal Antibodies Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Eli Lilly

11.1.1 Eli Lilly Company Information

11.1.2 Eli Lilly Long-Acting Monoclonal Antibodies Product Offered

11.1.3 Eli Lilly Long-Acting Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Eli Lilly Main Business Overview

11.1.5 Eli Lilly Latest Developments

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Information

11.2.2 Abbott Laboratories Long-Acting Monoclonal Antibodies Product Offered

11.2.3 Abbott Laboratories Long-Acting Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Abbott Laboratories Main Business Overview

11.2.5 Abbott Laboratories Latest Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Information

11.3.2 AstraZeneca Long-Acting Monoclonal Antibodies Product Offered

11.3.3 AstraZeneca Long-Acting Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 AstraZeneca Main Business Overview

11.3.5 AstraZeneca Latest Developments

11.4 Amgen

11.4.1 Amgen Company Information

11.4.2 Amgen Long-Acting Monoclonal Antibodies Product Offered

11.4.3 Amgen Long-Acting Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Amgen Main Business Overview

11.4.5 Amgen Latest Developments

11.5 Bayer AG

11.5.1 Bayer AG Company Information

11.5.2 Bayer AG Long-Acting Monoclonal Antibodies Product Offered

11.5.3 Bayer AG Long-Acting Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Bayer AG Main Business Overview

11.5.5 Bayer AG Latest Developments

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Information

11.6.2 Johnson & Johnson Long-Acting Monoclonal Antibodies Product Offered

11.6.3 Johnson & Johnson Long-Acting Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Johnson & Johnson Main Business Overview

11.6.5 Johnson & Johnson Latest Developments

11.7 Pfizer

11.7.1 Pfizer Company Information

11.7.2 Pfizer Long-Acting Monoclonal Antibodies Product Offered

11.7.3 Pfizer Long-Acting Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Pfizer Main Business Overview

11.7.5 Pfizer Latest Developments

11.8 GlaxoSmithKline

11.8.1 GlaxoSmithKline Company Information

11.8.2 GlaxoSmithKline Long-Acting Monoclonal Antibodies Product Offered

11.8.3 GlaxoSmithKline Long-Acting Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 GlaxoSmithKline Main Business Overview

11.8.5 GlaxoSmithKline Latest Developments

11.9 Merck

11.9.1 Merck Company Information

11.9.2 Merck Long-Acting Monoclonal Antibodies Product Offered

11.9.3 Merck Long-Acting Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Merck Main Business Overview

11.9.5 Merck Latest Developments

11.10 Novartis

11.10.1 Novartis Company Information

11.10.2 Novartis Long-Acting Monoclonal Antibodies Product Offered

11.10.3 Novartis Long-Acting Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Novartis Main Business Overview

11.10.5 Novartis Latest Developments

12 Research Findings and Conclusion

Table 1. Long-Acting Monoclonal Antibodies Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Murine Source

Table 3. Major Players of Chimeric Source

Table 4. Major Players of Human Source

Table 5. Long-Acting Monoclonal Antibodies Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Long-Acting Monoclonal Antibodies Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Long-Acting Monoclonal Antibodies Market Size Market Share by Type (2017-2022)

Table 8. Long-Acting Monoclonal Antibodies Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Long-Acting Monoclonal Antibodies Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Long-Acting Monoclonal Antibodies Market Size Market Share by Application (2017-2022)

Table 11. Global Long-Acting Monoclonal Antibodies Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Long-Acting Monoclonal Antibodies Revenue Market Share by Player (2020-2022)

Table 13. Long-Acting Monoclonal Antibodies Key Players Head office and Products Offered

Table 14. Long-Acting Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Long-Acting Monoclonal Antibodies Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Long-Acting Monoclonal Antibodies Market Size Market Share by Regions (2017-2022)

Table 19. Americas Long-Acting Monoclonal Antibodies Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Long-Acting Monoclonal Antibodies Market Size Market Share by Country (2017-2022)

Table 21. Americas Long-Acting Monoclonal Antibodies Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Long-Acting Monoclonal Antibodies Market Size Market Share by Type (2017-2022)

Table 23. Americas Long-Acting Monoclonal Antibodies Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Long-Acting Monoclonal Antibodies Market Size Market Share by Application (2017-2022)

Table 25. APAC Long-Acting Monoclonal Antibodies Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Long-Acting Monoclonal Antibodies Market Size Market Share by Region (2017-2022)

Table 27. APAC Long-Acting Monoclonal Antibodies Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Long-Acting Monoclonal Antibodies Market Size Market Share by Type (2017-2022)

Table 29. APAC Long-Acting Monoclonal Antibodies Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Long-Acting Monoclonal Antibodies Market Size Market Share by Application (2017-2022)

Table 31. Europe Long-Acting Monoclonal Antibodies Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Long-Acting Monoclonal Antibodies Market Size Market Share by Country (2017-2022)

Table 33. Europe Long-Acting Monoclonal Antibodies Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Long-Acting Monoclonal Antibodies Market Size Market Share by Type (2017-2022)

Table 35. Europe Long-Acting Monoclonal Antibodies Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Long-Acting Monoclonal Antibodies Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Long-Acting Monoclonal Antibodies

Table 44. Key Market Challenges & Risks of Long-Acting Monoclonal Antibodies

Table 45. Key Industry Trends of Long-Acting Monoclonal Antibodies

Table 46. Global Long-Acting Monoclonal Antibodies Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Long-Acting Monoclonal Antibodies Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Long-Acting Monoclonal Antibodies Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Long-Acting Monoclonal Antibodies Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Long-Acting Monoclonal Antibodies Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Long-Acting Monoclonal Antibodies Market Size Market Share Forecast by Application (2023-2028)

Table 52. Eli Lilly Details, Company Type, Long-Acting Monoclonal Antibodies Area Served and Its Competitors

Table 53. Eli Lilly Long-Acting Monoclonal Antibodies Product Offered

Table 54. Eli Lilly Long-Acting Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Eli Lilly Main Business

Table 56. Eli Lilly Latest Developments

Table 57. Abbott Laboratories Details, Company Type, Long-Acting Monoclonal Antibodies Area Served and Its Competitors

Table 58. Abbott Laboratories Long-Acting Monoclonal Antibodies Product Offered

Table 59. Abbott Laboratories Main Business

Table 60. Abbott Laboratories Long-Acting Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Abbott Laboratories Latest Developments

Table 62. AstraZeneca Details, Company Type, Long-Acting Monoclonal Antibodies Area Served and Its Competitors

Table 63. AstraZeneca Long-Acting Monoclonal Antibodies Product Offered

Table 64. AstraZeneca Main Business

Table 65. AstraZeneca Long-Acting Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. AstraZeneca Latest Developments

Table 67. Amgen Details, Company Type, Long-Acting Monoclonal Antibodies Area Served and Its Competitors

Table 68. Amgen Long-Acting Monoclonal Antibodies Product Offered

Table 69. Amgen Main Business

Table 70. Amgen Long-Acting Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Amgen Latest Developments

Table 72. Bayer AG Details, Company Type, Long-Acting Monoclonal Antibodies Area Served and Its Competitors

Table 73. Bayer AG Long-Acting Monoclonal Antibodies Product Offered

Table 74. Bayer AG Main Business

Table 75. Bayer AG Long-Acting Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Bayer AG Latest Developments

Table 77. Johnson & Johnson Details, Company Type, Long-Acting Monoclonal Antibodies Area Served and Its Competitors

Table 78. Johnson & Johnson Long-Acting Monoclonal Antibodies Product Offered

Table 79. Johnson & Johnson Main Business

Table 80. Johnson & Johnson Long-Acting Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Johnson & Johnson Latest Developments

Table 82. Pfizer Details, Company Type, Long-Acting Monoclonal Antibodies Area Served and Its Competitors

Table 83. Pfizer Long-Acting Monoclonal Antibodies Product Offered

Table 84. Pfizer Main Business

Table 85. Pfizer Long-Acting Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Pfizer Latest Developments

Table 87. GlaxoSmithKline Details, Company Type, Long-Acting Monoclonal Antibodies Area Served and Its Competitors

Table 88. GlaxoSmithKline Long-Acting Monoclonal Antibodies Product Offered

Table 89. GlaxoSmithKline Main Business

Table 90. GlaxoSmithKline Long-Acting Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. GlaxoSmithKline Latest Developments

Table 92. Merck Details, Company Type, Long-Acting Monoclonal Antibodies Area Served and Its Competitors

Table 93. Merck Long-Acting Monoclonal Antibodies Product Offered

Table 94. Merck Main Business

Table 95. Merck Long-Acting Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Merck Latest Developments

Table 97. Novartis Details, Company Type, Long-Acting Monoclonal Antibodies Area Served and Its Competitors

Table 98. Novartis Long-Acting Monoclonal Antibodies Product Offered

Table 99. Novartis Main Business

Table 100. Novartis Long-Acting Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Novartis Latest Developments

List of Figures

Figure 1. Long-Acting Monoclonal Antibodies Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Long-Acting Monoclonal Antibodies Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Long-Acting Monoclonal Antibodies Market Size Market Share by Type in 2021

Figure 7. Long-Acting Monoclonal Antibodies in Cancer

Figure 8. Global Long-Acting Monoclonal Antibodies Market: Cancer (2017-2022) & ($ Millions)

Figure 9. Long-Acting Monoclonal Antibodies in Autoimmune Diseases

Figure 10. Global Long-Acting Monoclonal Antibodies Market: Autoimmune Diseases (2017-2022) & ($ Millions)

Figure 11. Long-Acting Monoclonal Antibodies in Inflammatory Diseases

Figure 12. Global Long-Acting Monoclonal Antibodies Market: Inflammatory Diseases (2017-2022) & ($ Millions)

Figure 13. Long-Acting Monoclonal Antibodies in Infectious Diseases

Figure 14. Global Long-Acting Monoclonal Antibodies Market: Infectious Diseases (2017-2022) & ($ Millions)

Figure 15. Long-Acting Monoclonal Antibodies in Others

Figure 16. Global Long-Acting Monoclonal Antibodies Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Long-Acting Monoclonal Antibodies Market Size Market Share by Application in 2021

Figure 18. Global Long-Acting Monoclonal Antibodies Revenue Market Share by Player in 2021

Figure 19. Global Long-Acting Monoclonal Antibodies Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Long-Acting Monoclonal Antibodies Market Size 2017-2022 ($ Millions)

Figure 21. APAC Long-Acting Monoclonal Antibodies Market Size 2017-2022 ($ Millions)

Figure 22. Europe Long-Acting Monoclonal Antibodies Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size 2017-2022 ($ Millions)

Figure 24. Americas Long-Acting Monoclonal Antibodies Value Market Share by Country in 2021

Figure 25. Americas Long-Acting Monoclonal Antibodies Consumption Market Share by Type in 2021

Figure 26. Americas Long-Acting Monoclonal Antibodies Market Size Market Share by Application in 2021

Figure 27. United States Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Long-Acting Monoclonal Antibodies Market Size Market Share by Region in 2021

Figure 32. APAC Long-Acting Monoclonal Antibodies Market Size Market Share by Application in 2021

Figure 33. China Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Long-Acting Monoclonal Antibodies Market Size Market Share by Country in 2021

Figure 40. Europe Long-Acting Monoclonal Antibodies Market Size Market Share by Type in 2021

Figure 41. Europe Long-Acting Monoclonal Antibodies Market Size Market Share by Application in 2021

Figure 42. Germany Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size Market Share by Application in 2021

Figure 50. Egypt Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Long-Acting Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 56. APAC Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 57. Europe Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 59. United States Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 60. Canada Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 63. China Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 64. Japan Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 65. Korea Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 67. India Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 68. Australia Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 69. Germany Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 70. France Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 71. UK Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 72. Italy Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 73. Russia Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 74. Spain Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 77. Israel Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Long-Acting Monoclonal Antibodies Market Size 2023-2028 ($ Millions)